SCHEMBL15515501

SCHEMBL15515501

c1cc2[nH]ncc2cc1N1CCCC1

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 13/20 0.58
ROCK2 O75116 16/20 0.56
JAK2 O60674 2/20 0.50
GSK3B P49841 2/20 0.50
NOS1 P29475 3/20 0.49
METAP2 P50579 1/20 0.49
CSNK2A1 P68400 1/20 0.49
KDM4E B2RXH2 1/20 0.49
MEN1 O00255 1/20 0.49
ALDH1A1 P00352 1/20 0.49
GAA P10253 1/20 0.49
MAPT P10636 1/20 0.49
HPGD P15428 1/20 0.49
RAB9A P51151 1/20 0.49
KMT2A Q03164 1/20 0.49
ROCK1 Q13464 1/20 0.49
HIF1A Q16665 1/20 0.49
TDP1 Q9NUW8 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24172739 0.97 CYP3A4 (0.58) CYP3A4ROCK2JAK2GSK3BNOS1
SCHEMBL2798618 0.87 CDC7 (0.59) CYP3A4ROCK2ROCK1
Hydrochloric Acid SCHEMBL22412381 0.85 CDC7 (0.58) CYP3A4ROCK2ROCK1
SCHEMBL5412781 0.85 PLK4 (0.56) CYP3A4ROCK2
SCHEMBL30469212 0.85 TERT (0.53) CYP3A4ROCK2NOS1METAP2KDM4E
SCHEMBL5823182 0.83 CYP3A4 (0.55) CYP3A4ROCK2JAK2GSK3BKDM4E
SCHEMBL30385421 0.83 NOS1 (0.49) CYP3A4ROCK2NOS1METAP2KDM4E
SCHEMBL29039315 0.83 NOS1 (0.49) CYP3A4ROCK2NOS1METAP2KDM4E
SCHEMBL2230739 0.82 ROCK2 (0.46) CYP3A4ROCK2JAK2GSK3BROCK1
SCHEMBL24421947 0.82 CYP3A4 (0.57) CYP3A4ROCK2JAK2GSK3BROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2892892-A1 IMIDAZOLIN-5-ONE DERIVATIVES USEFUL AS FATTY ACID SNTHASE (FASN) INHIBITORS FOR!THE TREATMENT OF CANCER Janssen Pharmaceutica N.V. (BE) 2015-07-15 EP disclosed
WO-2014039769-A1 IMIDAZOLIN-5-ONE DERIVATIVES USEFUL AS FATTY ACID SNTHASE (FASN) INHIBITORS FOR|THE TREATMENT OF CANCER JANSSEN PHARMACEUTICA NV (BE) 2014-03-13 WO disclosed